Daridorexant for insomnia to improve sleep and daytime function
Treatments studied
Part of Brain & nervous system, Mental health clinical trials.
This trial tests a new medicine, daridorexant, to see if it helps people with insomnia sleep better through the night and feel more alert during the day. The study will use a home device to check your sleep patterns before you join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have trouble sleeping, such as difficulty falling asleep, staying asleep, or waking up too early, for at least 3 nights a week for 3 months or more.
- Your average sleep is 6.5 hours or less per night (based on a home sleep monitor for 7 nights).
- You do not have a history of breathing problems during sleep (like sleep apnea).
- You have not taken daridorexant or other similar medicines before.
- Your body mass index (BMI) is between 18.5 and 40.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows adults with insomnia who are prescribed a new sleep medication called daridorexant. It aims to see how well the medication works in a real-world setting, and to monitor its safety and effects on sleep.
This trial tests whether daridorexant can improve sleep in people who have mild cognitive impairment or early Alzheimer’s disease and struggle with insomnia. It may help by improving how long and how well you sleep, with monitoring of sleep patterns and memory-related measures.
This study tests whether switching from common sleeping pills (BZRAs) to a newer medicine called daridorexant helps people with insomnia sleep better and feel better during the day. It is for adults who are not fully satisfied with their current sleeping pill or have side effects from it.
This study tests an experimental sleep aid called daridorexant for people who have both depression and insomnia. It aims to see if the drug can improve sleep without worsening depression symptoms.
This study tests a sleep medication called daridorexant to see if it helps people with both insomnia and alcohol use disorder sleep better and reduce drinking. It may offer a new way to address both problems together.
This study tests whether daridorexant, a medication that helps improve sleep, can prevent Alzheimer's disease. If you have mild memory concerns but not dementia, this trial may help find out if better sleep can protect your brain.
Hear when a new Insomia Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.